# Investigation of Quantitative Trait Loci in Cavalier King Charles Spaniels with and without Chiari-like Malformation and Syringomyelia

> **NIH NIH F30** · NORTH CAROLINA STATE UNIVERSITY RALEIGH · 2020 · $38,610

## Abstract

Project Summary/Abstract:
 Chiari-type I malformation (CM1) is a developmental disorder estimated to affect 215,000 Americans. It is
characterized by caudal herniation of the cerebellar tonsils below the foramen magnum and is frequently
associated with syringomyelia (SM). In Cavalier King Charles Spaniels (CKCS), like people, Chiari-like
malformations result in a brain and skull mismatch that produces a relatively small caudal fossa with crowding
of the foramen magnum, and stenosis of the cranial venous sinuses and skull foramina. These changes
conspire to produce turbulent flow of cerebrospinal fluid (CSF) and development of SM within the spinal cord.
The CMSM complex in CKCS causes severe neuropathic pain mainly localized to the head and neck region
manifesting as phantom scratching (scratching of the head and neck without making skin contact), sensitivity to
touch, and screaming in pain. Similarly, clinical presentation of CM1 in humans is dominated by manifestations
of neuropathic pain including occipital and upper cervical pain, and burning sensations of the upper
extremities. A genetic basis for the human and canine condition have been inferred, however, many causes
remain unknown. We propose that CMSM in CKCS is a model of CM1 in humans and that genetic discovery in
this breed will have relevance for the human condition. In this project, we will leverage the genetic
homogeneity of dog breeds to identify novel genetic variants associated with CMSM. These variants, and the
pathways that they highlight, can then be investigated in humans with CM1.
Our laboratory has developed clinical metrology tools to quantify the clinical phenotype and has extensive
experience quantifying the morphological characteristics of CMSM in CKCS on MRI. In collaboration with Dr.
Trudy Mackay's genetics laboratory, we will perform association mapping to identify variants using both case-
control and quantitative trait study design. The primary purpose of this study is to identify loci associated with
CMSM in CKCS but a preliminary examination of these loci for causative mutations will be performed. We
propose to use both categorical and continuous measures of severity of CMSM based on morphologic MRI
findings, as well as measures of neuropathic pain signs including owner-reported questionnaire data, and
neurological examination findings. We hypothesize that quantitative trait loci (QTL) associated with CMSM
in CKCS can be identified using a genome-wide association study and quantitative phenotypes. At the
completion of this study, we will have uncovered novel loci associated with CMSM morphological changes
and/or neuropathic pain that will be investigated for genetic variants associated with the traits. This work will
pave the road for collaborative studies on the genetic basis of CM1 and associated neuropathic pain in
humans.

## Key facts

- **NIH application ID:** 9951126
- **Project number:** 5F30OD025357-03
- **Recipient organization:** NORTH CAROLINA STATE UNIVERSITY RALEIGH
- **Principal Investigator:** Courtney Rousse
- **Activity code:** F30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $38,610
- **Award type:** 5
- **Project period:** 2018-07-01 → 2022-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9951126

## Citation

> US National Institutes of Health, RePORTER application 9951126, Investigation of Quantitative Trait Loci in Cavalier King Charles Spaniels with and without Chiari-like Malformation and Syringomyelia (5F30OD025357-03). Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/grant/nih/9951126. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*